Major molecular response in CML patients treated with tyrosine kinase inhibitors: The paradigm for monitoring targeted cancer therapy

Richard D. Press

Research output: Contribution to journal › Article › peer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Major molecular response in CML patients treated with tyrosine kinase inhibitors: The paradigm for monitoring targeted cancer therapy'. Together they form a unique fingerprint.